CTO: Length’s Impact on Success

The rise of chronic total occlusions (CTO) percutaneous coronary interventions (PCI) goes hand in hand with technological development, through still posing a great challenge, one not exactly exempt from complications. 

CTO: la longitud impacta en el éxito

An important criterion to successful CTO PCI is length: ≥20 mm lesions lower the odds, according to J-CTO Score. However, increasing operator experience and the development of new guidewires and micro-catheters is gradually changing the situation.

The study looked at 10335 CTO PCI performed between 2012 and 2022. 7208 of these interventions were ≥20 mm long (69.7%) and 3127 <20 mm long (30.3%).

Mean age was similar in both groups, but those with ≥20 mm occlusions were more often men, smokers, presenting hypertension, dyslipidemia, diabetes, peripheral vascular disease, cardiac failure, lower ejection fraction, MI, and CABG. 

The artery that more frequently presented CTO was the right coronary (57.3%), followed by the anterior descending (23.4%) and the circumflex.

Read also: ISAR Score: Can We Predict the Need for Repeat PCI in DES Restenosis?

≥20 mm occlusions presented more unfavorable angiographic characteristics, more tortuosity, and severe calcification. Also, the dissection and reentry technique was more often used in the group, as well as the retrograde strategy.

Crossing success rate was lower in patients presenting longer lesions, who also needed more stents, longer fluoroscopy time and longer procedures. 

≥20 mm lesions were associated to lower technical and procedural success (84.4% vs. 91.8%; p < 0.001 and 81.9% vs. 90.3%; p < 0.001 respectively). In hospital MACE was higher in this group (3.4% vs. 1.9%; p < 0.001), as was AMI (0.7% vs. 0.26%; p = 0.009), perforations (5.15% vs. 3.87%; p = 0.007) and the presence of thrombi and dissection (0.84% vs. 0.35%; p = 0.008).

Read also: Percutaneous Access Closure in TAVR: Are Devices Similar?

A 10 mm increase in occlusion length was associated to lower technical success rate. 

After multivariable analysis, (shorter) lesion length was associated to reduced MACE and technical success. 

Conclusion

CTO PCI of long occlusions is independently associated with lower rates of technical success and higher rates of in-hospital MACE. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS‐CTO registry.

Reference: Athanasios Rempakos, et al. Catheter Cardiovasc Interv. 2023;101:747–755.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...